Authors: Schauer J, Buddhe S, Gulhane A, Sagiv E
PMID: 35351530 PMCID: PMC8957353 DOI: 10.1016/j.jpeds.2022.03.032
Abstract
We describe the evolution of cardiac magnetic resonance imaging findings in 16 patients, aged 12-17 years, with myopericarditis after the second dose of the Pfizer mRNA coronavirus disease 2019 vaccine. Although all patients showed rapid clinical improvement, many had persistent cardiac magnetic resonance imaging findings at 3- to 8-month follow-up.
Keywords: COVID-19 mRNA Vaccine, Cardiac MRI, Myopericarditis
Source: https://pubmed.ncbi.nlm.nih.gov/35351530/
Archive: https://archive.is/ReXBT